Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

What Happened: Purdue Pharma developed and aggressively marketed OxyContin starting in the 1990s via medical sales reps whose job was to convince doctors to prescribe more of their drug.

Copyright 2025 The Associated Press. All Rights Reserved. Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7. ...

Purdue Pharma and the Sackler family will pay $7.4 billion for their role in the opioid epidemic. Delaware will receive over $27 million from the settlement. The settlement comes just shy of a ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...

The deal would also end the Sacklers’ control of Purdue. The fate of the company itself, which remains in Chapter 11 bankruptcy since filing in 2019, will be determined by a board of trustees ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...